[go: up one dir, main page]

AR011805A1 - Composicion farmaceutica para administracion oral de un principio activo. - Google Patents

Composicion farmaceutica para administracion oral de un principio activo.

Info

Publication number
AR011805A1
AR011805A1 ARP980100675A ARP980100675A AR011805A1 AR 011805 A1 AR011805 A1 AR 011805A1 AR P980100675 A ARP980100675 A AR P980100675A AR P980100675 A ARP980100675 A AR P980100675A AR 011805 A1 AR011805 A1 AR 011805A1
Authority
AR
Argentina
Prior art keywords
omega
alkylene
group
formula
weight
Prior art date
Application number
ARP980100675A
Other languages
English (en)
Original Assignee
Wicke K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wicke K filed Critical Wicke K
Publication of AR011805A1 publication Critical patent/AR011805A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Una composicion farmacéutica para administracion oral de compuestos heterocíclicos en forma de amonio cuaternario, que contiene: principio activo0,1 a 15% en peso, solvente hidrofilo 0 a 60% en peso, tensioactivo ionico 0 a 5% de peso, polisorbato 80 0 a 5% de peso, macrogoglicérido Q.S. para 100% depeso, con la condicion de que esté presente al menos un constituyente elegido entre el solvente hidrofilo y el tensioactivo ionico. Esta composicionfarmacéutica permite mejorar la biodisponibilidad del principio activo. El principio activo responde a la formula I en la cual: -A(-) es un anionfarmacéuticamente aceptable; -Am(+) representa: i- o bien un grupo Am1(+) de formula II; ii- o bien un grupo Am2(+) de formula III, iii-o bien un grupoAm3(+) de formula IV ; iv- o bien un grupo Am4(+) de formula: V; v o bien un grupo Am5(+) de formula VI; Ar representa un fenilo no substituido osubstituido una o dos veces por un substituyente, un naftilo; un indolilo; Q e Y representan uno de los grupos de valores siguientes: a) Q1 e Y1; b) Q2 e Y2cuando Am(+) representa un grupo Am1(+), Am2(+), Am4(+) o Am5(+), c) Q3 e Y3 cuando Am (+) representa un grupo Am1(+, Am2(+), o un grupo Am4(+) en el cual Ar1 representa un fenilo y p es dos; d) Q4 e Y4 cuando Am(+) representa un grupo Am1(+), Am3(+), Am4(+) o Am5(+); Q1 representa al hidrogeno; Y1 representa alhidrogeno; un (C1-C4)alquilo; un omega-(C1-C4)alcoxi-(C2-C4)alquileno; un omega-(C1-C4)alquilcaboniloxi-(C2-C4)alquileno; un omega-benzoiloxi-(C2-C4)alquileno; un omega-hidroxi-(C2-C4)alquileno; un omega-(C1-C4)alquiltio- -(C2-C4)alquileno; un omega-(C1-C4)alquilcarbonil-(C2-C4)alquileno; un omega--carboxi-(C2-C4)alquileno; un omega-(C1-C4)alcoxicarbonil-(C2-C4)alquileno, un omega-benciloxi(C2-C4)alquileno; un omega-formiloxi-(C2-C4)alquileno; un
ARP980100675A 1997-02-17 1998-02-16 Composicion farmaceutica para administracion oral de un principio activo. AR011805A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9701825A FR2759584B1 (fr) 1997-02-17 1997-02-17 Composition pharmaceutique pour l'administration orale de composes heterocycliques sous forme ammonium quaternaire

Publications (1)

Publication Number Publication Date
AR011805A1 true AR011805A1 (es) 2000-09-13

Family

ID=9503804

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100675A AR011805A1 (es) 1997-02-17 1998-02-16 Composicion farmaceutica para administracion oral de un principio activo.

Country Status (11)

Country Link
EP (1) EP0969825A1 (es)
JP (1) JP2001511795A (es)
AR (1) AR011805A1 (es)
AU (1) AU6404998A (es)
BR (1) BR9807694A (es)
CA (1) CA2281560A1 (es)
FR (1) FR2759584B1 (es)
HR (1) HRP980075A2 (es)
NO (1) NO993928D0 (es)
WO (1) WO1998035662A1 (es)
ZA (1) ZA981289B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102188424B (zh) * 2011-03-23 2013-03-27 浙江理工大学 Sr140333的抗血癌作用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) * 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
FR2696178B1 (fr) * 1992-09-30 1994-12-30 Sanofi Elf Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2717804B1 (fr) * 1994-03-25 1996-06-21 Sanofi Sa Sels de composés hétéroaromatiques azotés substitués, procédé pour leur préparation et compositions pharmaceutiques en contenant.
CN1067385C (zh) * 1994-08-25 2001-06-20 默里尔药物公司 用于治疗变应性疾病的新的取代的哌啶类化合物
FR2725986B1 (fr) * 1994-10-21 1996-11-29 Adir Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2725900B1 (fr) * 1994-10-21 1997-07-18 Sanofi Sa Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice
FR2729951B1 (fr) * 1995-01-30 1997-04-18 Sanofi Sa Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
EP0969825A1 (fr) 2000-01-12
WO1998035662A1 (fr) 1998-08-20
BR9807694A (pt) 2000-03-21
CA2281560A1 (en) 1998-08-20
AU6404998A (en) 1998-09-08
ZA981289B (en) 1998-08-26
HRP980075A2 (en) 1998-10-31
NO993928L (no) 1999-08-16
FR2759584A1 (fr) 1998-08-21
NO993928D0 (no) 1999-08-16
FR2759584B1 (fr) 1999-06-11
JP2001511795A (ja) 2001-08-14

Similar Documents

Publication Publication Date Title
CO5251429A1 (es) Derivados de ter-butil-(7-metil-imidazo(1,2-a)piridin-3- il)-amina procedimiento para su preparacion, medicamentos que los contienen, su uso para la preparacion de un medicamento para la inhibicion de la no-sintasa y composiciones farmaceuticas que l
KR950007859A (ko) 경구 투여용 라파마이신 제형
NO20045072L (no) Tablett med hoyt medikamentinnhold
AR065937A2 (es) Compuesto derivado indazol, composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para modular la actividad de proteina quinasa
AR023971A1 (es) Derivados de 4,5,6,7-tetrahidroindazol, procedimiento para la preparacion de los mismos y su utilizacion como agentes antitumorales
NO20000466D0 (no) Farmasoeytisk preparat for sure, lipofile forbindelser i form av en selvemulgerende formulering
CA2383298A1 (fr) Nouveaux derives d'.alpha.-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE409461T1 (de) Hfc lösungsformulierungen enthaltend ein anticholinergikum
AR033688A1 (es) Composicion parenteral reconstituible
RU2017118335A (ru) Гетероциклическое производное, обладающее активирующей ampk активностью
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
JP2000159790A5 (es)
KR900016196A (ko) 테트라하이드로벤즈[c, d]인돌 세로토닌 효능제
DE60042831D1 (de) Pharmazeutisch aktive sulfonylaminosäurederivate
ATE281464T1 (de) Adenosinderivate und deren verwendung
AR009251A1 (es) Compuestos de ácido 4-oxo-butanoico y composiciones que los contienen
AR011805A1 (es) Composicion farmaceutica para administracion oral de un principio activo.
DK122191D0 (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
ES2618374T3 (es) Composiciones y métodos para mejorar la absorción de glucosa
KR920019350A (ko) 자기면역질환요법을 위한 약제조성물
AR045912A1 (es) Composiciones farmaceuticas que contienen derivados de azetidina
KR900012925A (ko) 인돌 유도체
MX9206930A (es) Nuevos compuestos
AR029250A1 (es) Derivados de milbemicina, composicion que los comprende y el uso de los mismos para la elaboracion de un medicamento contra insectos y otras plagas.
RU98106104A (ru) Производные пиримидина